Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Preferred Shares (2022 - 2025)

Neuraxis (NRXS) posted Preferred Shares of $3797.0 for Q4 2025, down 2.57% sequentially from $3897.0 in Q3 2025, and down 11.31% YoY from $4281.0 in Q4 2024.

Neuraxis (NRXS) Preferred Shares (2022 - 2025) Analysis & Trends

Neuraxis has reported Preferred Shares for 4 years, with the latest figure at $3797.0 in Q4 2025.

  • Quarterly Preferred Shares fell 11.31% year-over-year to $3797.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3797.0 (down 11.31% YoY) and the FY2025 annual result came in at $3797.0, down 11.31% from the prior year.
  • Preferred Shares fell to $3797.0 in Q4 2025 per NRXS's latest filing, from $3897.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $4281.0 in Q4 2024 and troughed at $115.0 in Q2 2023.
  • A 4-year average of $2856.1 and a median of $3847.0 in 2025 frame the typical range for Preferred Shares.
  • The widest YoY moves for Preferred Shares: up 87.9% in 2025, down 11.31% in 2025.
  • Over 4 years, Preferred Shares stood at $507.0 in 2022, then plunged by 77.32% to $115.0 in 2023, then soared by 3622.61% to $4281.0 in 2024, then retreated by 11.31% to $3797.0 in 2025.
  • According to Business Quant data, Preferred Shares over the past three periods registered $3797.0, $3897.0, and $3897.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 3,797.00
Sep 30, 2025 3,897.00
Jun 30, 2025 3,897.00
Mar 31, 2025 4,281.00
Dec 31, 2024 4,281.00
Sep 30, 2024 2,074.00
Jun 30, 2023 115.00
Dec 31, 2022 507.00